Gulf International Bank (Uk) LTD Biogen Inc. Transaction History

Gulf International Bank (Uk) LTD

$2.9 Billion
Q1 2025

A detailed history of Gulf International Bank (Uk) LTD transactions in Biogen Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 7,924 shares of BIIB stock, worth $999,057. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,924

Previous 11,323 30.02%

Holding current value

$999,057

Previous $1.73 Million 37.38%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$133.43 - $153.27 $453,528 - $520,964	-3,399 Reduced 30.02%	7,924 $1.08 Million
Q4 2024 Feb 05, 2025	SELL	$146.47 - $191.55 $16,844 - $22,028	-115 Reduced 1.01%	11,323 $1.73 Million
Q3 2024 Oct 30, 2024	SELL	$189.07 - $236.8 $96,614 - $121,004	-511 Reduced 4.28%	11,438 $2.22 Million
Q2 2024 Jul 10, 2024	SELL	$190.52 - $236.72 $91,449 - $113,625	-480 Reduced 3.86%	11,949 $2.77 Million
Q1 2024 Apr 11, 2024	BUY	$212.02 - $267.71 $13,357 - $16,865	63 Added 0.51%	12,429 $2.68 Million
Q4 2023 Jan 11, 2024	SELL	$222.59 - $267.94 $319,861 - $385,029	-1,437 Reduced 10.41%	12,366 $3.2 Million
Q3 2023 Oct 10, 2023	SELL	$253.3 - $285.89 $342,208 - $386,237	-1,351 Reduced 8.92%	13,803 $3.55 Million
Q2 2023 Aug 02, 2023	SELL	$275.25 - $318.06 $1.03 Million - $1.19 Million	-3,742 Reduced 19.8%	15,154 $4.32 Million
Q1 2023 Apr 12, 2023	SELL	$256.56 - $292.34 $1.87 Million - $2.13 Million	-7,281 Reduced 27.81%	18,896 $5.25 Million
Q3 2022 Oct 07, 2022	SELL	$194.69 - $268.46 $248,229 - $342,286	-1,275 Reduced 4.64%	26,177 $6.99 Million
Q2 2022 Jul 19, 2022	BUY	$187.54 - $223.02 $75,016 - $89,208	400 Added 1.48%	27,452 $5.63 Million
Q4 2021 Jan 24, 2022	SELL	$223.92 - $287.77 $1.06 Million - $1.37 Million	-4,756 Reduced 14.95%	27,052 $6.49 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $103,574 - $135,072	-366 Reduced 1.14%	31,808 $9 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $148,925 - $238,458	-575 Reduced 1.76%	32,174 $11.1 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $835,748 - $979,127	-3,440 Reduced 9.51%	32,749 $9.16 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.27 Million - $1.91 Million	-5,370 Reduced 12.92%	36,189 $8.86 Million
Q3 2020 Oct 21, 2020	SELL	$264.77 - $305.71 $409,863 - $473,239	-1,548 Reduced 3.59%	41,559 $11.8 Million
Q2 2020 Jul 24, 2020	SELL	$258.66 - $342.55 $511,888 - $677,906	-1,979 Reduced 4.39%	43,107 $11.5 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $275,571 - $349,566	-1,025 Reduced 2.22%	45,086 $14.3 Million
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $44,012 - $60,814	-200 Reduced 0.43%	46,111 $13.7 Million
Q3 2019 Oct 08, 2019	SELL	$217.44 - $243.88 $64,144 - $71,944	-295 Reduced 0.63%	46,311 $10.8 Million
Q2 2019 Jul 10, 2019	SELL	$219.29 - $241.72 $611,380 - $673,915	-2,788 Reduced 5.64%	46,606 $10.9 Million
Q1 2019 Apr 18, 2019	BUY	$216.71 - $338.96 $14,086 - $22,032	65 Added 0.13%	49,394 $11.7 Million
Q4 2018 Jan 08, 2019	SELL	$278.5 - $352.75 $6.34 Million - $8.02 Million	-22,749 Reduced 31.56%	49,329 $14.8 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $1.5 Million - $1.96 Million	5,097 Added 7.61%	72,078 $25.5 Million
Q2 2018 Jul 05, 2018	BUY	$257.52 - $306.91 $25,752 - $30,691	100 Added 0.15%	66,981 $19.4 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $185,992 - $263,055	-715 Reduced 1.06%	66,881 $18.3 Million
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $18,458 - $20,674	-60 Reduced 0.09%	67,596 $21.5 Million
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $19 Million - $22.3 Million	67,656	67,656 $21.2 Million

Others Institutions Holding BIIB

# of Institutions

1,027

Shares Held

127M

Call Options Held

2.29M

Put Options Held

4.26M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Account

Gulf International Bank (Uk) LTD Biogen Inc. Transaction History